Jennifer Quint is a Professor of Respiratory Epidemiology at the National Heart and Lung Institute and Honorary Consultant Physician in Respiratory Medicine at the Royal Brompton and Imperial College London NHS Foundation Trusts.
Dr Quint’s research interests centre on the use of electronic health records to study chronic obstructive pulmonary disease (COPD) as well as other chronic respiratory diseases including asthma, ILD and bronchiectasis. She leads a clinical epidemiology research group whose work centres largely on understanding the relationship between cardiovascular and respiratory disease as well as maximising the quality, linkage and usage of routinely collected data for clinical and research purposes. The majority of her work has been on exacerbations of COPD, exploring both the effect of COPD exacerbations on vascular outcomes and the relationship between environmental factors and exacerbations of COPD.
et al., 2020, Real world effects of COPD medications: a cohort study with validation against RCT results, European Respiratory Journal, ISSN:0903-1936
et al., Lung Volume Reduction eligibility in COPD patients attending Pulmonary Rehabilitation – results from the UK National Asthma and COPD Audit Programme, Bmj Open, ISSN:2044-6055
et al., 2020, Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease, Pulmonary Therapy, ISSN:2364-1746
et al., 2020, Outcome of hospitalization for COVID-19 in patients with interstitial lung disease: an international multicenter study., American Journal of Respiratory and Critical Care Medicine, ISSN:1073-449X
et al., 2020, Asthma-related health outcomes associated with short-acting beta(2)-agonist inhaler use: an observational UK study as part of the SABINA global program, Advances in Therapy, Vol:37, ISSN:0741-238X, Pages:4190-4208